Medical Care

Global Small Scale Plasma Fractionation Market Outlook, In‑Depth Analysis & Forecast to 2031

Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Small Scale Plasma Fractionation market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
Segment by Type
Immune Globulin
Coagulation Factor
Albumin
Others
Segment by Application
Hospital
Retail Pharmacy
Others
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Small Scale Plasma Fractionation study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Small Scale Plasma Fractionation: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Small Scale Plasma Fractionation Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Immune Globulin
1.2.3 Coagulation Factor
1.2.4 Albumin
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Small Scale Plasma Fractionation Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Small Scale Plasma Fractionation Revenue Estimates and Forecasts 2020-2031
2.2 Global Small Scale Plasma Fractionation Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Small Scale Plasma Fractionation Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Small Scale Plasma Fractionation Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Immune Globulin Market Size by Players
3.3.2 Coagulation Factor Market Size by Players
3.3.3 Albumin Market Size by Players
3.3.4 Others Market Size by Players
3.4 Global Small Scale Plasma Fractionation Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Small Scale Plasma Fractionation Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Small Scale Plasma Fractionation Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Small Scale Plasma Fractionation Market Size by Type (2020-2031)
6.4 North America Small Scale Plasma Fractionation Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Small Scale Plasma Fractionation Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Small Scale Plasma Fractionation Market Size by Type (2020-2031)
7.4 Europe Small Scale Plasma Fractionation Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Small Scale Plasma Fractionation Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Small Scale Plasma Fractionation Market Size by Type (2020-2031)
8.4 Asia-Pacific Small Scale Plasma Fractionation Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Small Scale Plasma Fractionation Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Small Scale Plasma Fractionation Market Size by Type (2020-2031)
9.4 Central and South America Small Scale Plasma Fractionation Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Small Scale Plasma Fractionation Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Small Scale Plasma Fractionation Market Size by Type (2020-2031)
10.4 Middle East and Africa Small Scale Plasma Fractionation Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Small Scale Plasma Fractionation Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Takeda
11.1.1 Takeda Corporation Information
11.1.2 Takeda Business Overview
11.1.3 Takeda Small Scale Plasma Fractionation Product Features and Attributes
11.1.4 Takeda Small Scale Plasma Fractionation Revenue and Gross Margin (2020-2025)
11.1.5 Takeda Small Scale Plasma Fractionation Revenue by Product in 2024
11.1.6 Takeda Small Scale Plasma Fractionation Revenue by Application in 2024
11.1.7 Takeda Small Scale Plasma Fractionation Revenue by Geographic Area in 2024
11.1.8 Takeda Small Scale Plasma Fractionation SWOT Analysis
11.1.9 Takeda Recent Developments
11.2 CSL
11.2.1 CSL Corporation Information
11.2.2 CSL Business Overview
11.2.3 CSL Small Scale Plasma Fractionation Product Features and Attributes
11.2.4 CSL Small Scale Plasma Fractionation Revenue and Gross Margin (2020-2025)
11.2.5 CSL Small Scale Plasma Fractionation Revenue by Product in 2024
11.2.6 CSL Small Scale Plasma Fractionation Revenue by Application in 2024
11.2.7 CSL Small Scale Plasma Fractionation Revenue by Geographic Area in 2024
11.2.8 CSL Small Scale Plasma Fractionation SWOT Analysis
11.2.9 CSL Recent Developments
11.3 Grifols
11.3.1 Grifols Corporation Information
11.3.2 Grifols Business Overview
11.3.3 Grifols Small Scale Plasma Fractionation Product Features and Attributes
11.3.4 Grifols Small Scale Plasma Fractionation Revenue and Gross Margin (2020-2025)
11.3.5 Grifols Small Scale Plasma Fractionation Revenue by Product in 2024
11.3.6 Grifols Small Scale Plasma Fractionation Revenue by Application in 2024
11.3.7 Grifols Small Scale Plasma Fractionation Revenue by Geographic Area in 2024
11.3.8 Grifols Small Scale Plasma Fractionation SWOT Analysis
11.3.9 Grifols Recent Developments
11.4 Octapharma
11.4.1 Octapharma Corporation Information
11.4.2 Octapharma Business Overview
11.4.3 Octapharma Small Scale Plasma Fractionation Product Features and Attributes
11.4.4 Octapharma Small Scale Plasma Fractionation Revenue and Gross Margin (2020-2025)
11.4.5 Octapharma Small Scale Plasma Fractionation Revenue by Product in 2024
11.4.6 Octapharma Small Scale Plasma Fractionation Revenue by Application in 2024
11.4.7 Octapharma Small Scale Plasma Fractionation Revenue by Geographic Area in 2024
11.4.8 Octapharma Small Scale Plasma Fractionation SWOT Analysis
11.4.9 Octapharma Recent Developments
11.5 Kedrion
11.5.1 Kedrion Corporation Information
11.5.2 Kedrion Business Overview
11.5.3 Kedrion Small Scale Plasma Fractionation Product Features and Attributes
11.5.4 Kedrion Small Scale Plasma Fractionation Revenue and Gross Margin (2020-2025)
11.5.5 Kedrion Small Scale Plasma Fractionation Revenue by Product in 2024
11.5.6 Kedrion Small Scale Plasma Fractionation Revenue by Application in 2024
11.5.7 Kedrion Small Scale Plasma Fractionation Revenue by Geographic Area in 2024
11.5.8 Kedrion Small Scale Plasma Fractionation SWOT Analysis
11.5.9 Kedrion Recent Developments
11.6 LFB Group
11.6.1 LFB Group Corporation Information
11.6.2 LFB Group Business Overview
11.6.3 LFB Group Small Scale Plasma Fractionation Product Features and Attributes
11.6.4 LFB Group Small Scale Plasma Fractionation Revenue and Gross Margin (2020-2025)
11.6.5 LFB Group Recent Developments
11.7 Biotest
11.7.1 Biotest Corporation Information
11.7.2 Biotest Business Overview
11.7.3 Biotest Small Scale Plasma Fractionation Product Features and Attributes
11.7.4 Biotest Small Scale Plasma Fractionation Revenue and Gross Margin (2020-2025)
11.7.5 Biotest Recent Developments
11.8 BPL
11.8.1 BPL Corporation Information
11.8.2 BPL Business Overview
11.8.3 BPL Small Scale Plasma Fractionation Product Features and Attributes
11.8.4 BPL Small Scale Plasma Fractionation Revenue and Gross Margin (2020-2025)
11.8.5 BPL Recent Developments
11.9 RAAS
11.9.1 RAAS Corporation Information
11.9.2 RAAS Business Overview
11.9.3 RAAS Small Scale Plasma Fractionation Product Features and Attributes
11.9.4 RAAS Small Scale Plasma Fractionation Revenue and Gross Margin (2020-2025)
11.9.5 RAAS Recent Developments
11.10 CBPO
11.10.1 CBPO Corporation Information
11.10.2 CBPO Business Overview
11.10.3 CBPO Small Scale Plasma Fractionation Product Features and Attributes
11.10.4 CBPO Small Scale Plasma Fractionation Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Hualan Bio
11.11.1 Hualan Bio Corporation Information
11.11.2 Hualan Bio Business Overview
11.11.3 Hualan Bio Small Scale Plasma Fractionation Product Features and Attributes
11.11.4 Hualan Bio Small Scale Plasma Fractionation Revenue and Gross Margin (2020-2025)
11.11.5 Hualan Bio Recent Developments
11.12 Tiantan Bio
11.12.1 Tiantan Bio Corporation Information
11.12.2 Tiantan Bio Business Overview
11.12.3 Tiantan Bio Small Scale Plasma Fractionation Product Features and Attributes
11.12.4 Tiantan Bio Small Scale Plasma Fractionation Revenue and Gross Margin (2020-2025)
11.12.5 Tiantan Bio Recent Developments
11.13 Shuanglin Bio
11.13.1 Shuanglin Bio Corporation Information
11.13.2 Shuanglin Bio Business Overview
11.13.3 Shuanglin Bio Small Scale Plasma Fractionation Product Features and Attributes
11.13.4 Shuanglin Bio Small Scale Plasma Fractionation Revenue and Gross Margin (2020-2025)
11.13.5 Shuanglin Bio Recent Developments
11.14 Boya Bio
11.14.1 Boya Bio Corporation Information
11.14.2 Boya Bio Business Overview
11.14.3 Boya Bio Small Scale Plasma Fractionation Product Features and Attributes
11.14.4 Boya Bio Small Scale Plasma Fractionation Revenue and Gross Margin (2020-2025)
11.14.5 Boya Bio Recent Developments
11.15 Yuanda Shuyang
11.15.1 Yuanda Shuyang Corporation Information
11.15.2 Yuanda Shuyang Business Overview
11.15.3 Yuanda Shuyang Small Scale Plasma Fractionation Product Features and Attributes
11.15.4 Yuanda Shuyang Small Scale Plasma Fractionation Revenue and Gross Margin (2020-2025)
11.15.5 Yuanda Shuyang Recent Developments
11.16 Weiguang Bio
11.16.1 Weiguang Bio Corporation Information
11.16.2 Weiguang Bio Business Overview
11.16.3 Weiguang Bio Small Scale Plasma Fractionation Product Features and Attributes
11.16.4 Weiguang Bio Small Scale Plasma Fractionation Revenue and Gross Margin (2020-2025)
11.16.5 Weiguang Bio Recent Developments
11.17 Nanyue Bio
11.17.1 Nanyue Bio Corporation Information
11.17.2 Nanyue Bio Business Overview
11.17.3 Nanyue Bio Small Scale Plasma Fractionation Product Features and Attributes
11.17.4 Nanyue Bio Small Scale Plasma Fractionation Revenue and Gross Margin (2020-2025)
11.17.5 Nanyue Bio Recent Developments
11.18 KM Biologics
11.18.1 KM Biologics Corporation Information
11.18.2 KM Biologics Business Overview
11.18.3 KM Biologics Small Scale Plasma Fractionation Product Features and Attributes
11.18.4 KM Biologics Small Scale Plasma Fractionation Revenue and Gross Margin (2020-2025)
11.18.5 KM Biologics Recent Developments
12 Small Scale Plasma FractionationIndustry Chain Analysis
12.1 Small Scale Plasma Fractionation Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Small Scale Plasma Fractionation Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Small Scale Plasma Fractionation Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Small Scale Plasma Fractionation Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Small Scale Plasma Fractionation Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Small Scale Plasma Fractionation Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Small Scale Plasma Fractionation Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Small Scale Plasma Fractionation Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Small Scale Plasma Fractionation Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Small Scale Plasma Fractionation Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Small Scale Plasma Fractionation by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Scale Plasma Fractionation as of 2024)
Table 11. Global Small Scale Plasma Fractionation Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Small Scale Plasma Fractionation Companies Headquarters
Table 13. Global Small Scale Plasma Fractionation Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Small Scale Plasma Fractionation Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Small Scale Plasma Fractionation Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Small Scale Plasma Fractionation Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Small Scale Plasma Fractionation Revenue by Application (2026-2031) & (US$ Million)
Table 21. Small Scale Plasma Fractionation High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Small Scale Plasma Fractionation Growth Accelerators and Market Barriers
Table 25. North America Small Scale Plasma Fractionation Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Small Scale Plasma Fractionation Growth Accelerators and Market Barriers
Table 27. Europe Small Scale Plasma Fractionation Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Small Scale Plasma Fractionation Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Small Scale Plasma Fractionation Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Small Scale Plasma Fractionation Investment Opportunities and Key Challenges
Table 31. Central and South America Small Scale Plasma Fractionation Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Small Scale Plasma Fractionation Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Small Scale Plasma Fractionation Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Takeda Corporation Information
Table 35. Takeda Description and Major Businesses
Table 36. Takeda Product Features and Attributes
Table 37. Takeda Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Takeda Revenue Proportion by Product in 2024
Table 39. Takeda Revenue Proportion by Application in 2024
Table 40. Takeda Revenue Proportion by Geographic Area in 2024
Table 41. Takeda Small Scale Plasma Fractionation SWOT Analysis
Table 42. Takeda Recent Developments
Table 43. CSL Corporation Information
Table 44. CSL Description and Major Businesses
Table 45. CSL Product Features and Attributes
Table 46. CSL Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. CSL Revenue Proportion by Product in 2024
Table 48. CSL Revenue Proportion by Application in 2024
Table 49. CSL Revenue Proportion by Geographic Area in 2024
Table 50. CSL Small Scale Plasma Fractionation SWOT Analysis
Table 51. CSL Recent Developments
Table 52. Grifols Corporation Information
Table 53. Grifols Description and Major Businesses
Table 54. Grifols Product Features and Attributes
Table 55. Grifols Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Grifols Revenue Proportion by Product in 2024
Table 57. Grifols Revenue Proportion by Application in 2024
Table 58. Grifols Revenue Proportion by Geographic Area in 2024
Table 59. Grifols Small Scale Plasma Fractionation SWOT Analysis
Table 60. Grifols Recent Developments
Table 61. Octapharma Corporation Information
Table 62. Octapharma Description and Major Businesses
Table 63. Octapharma Product Features and Attributes
Table 64. Octapharma Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Octapharma Revenue Proportion by Product in 2024
Table 66. Octapharma Revenue Proportion by Application in 2024
Table 67. Octapharma Revenue Proportion by Geographic Area in 2024
Table 68. Octapharma Small Scale Plasma Fractionation SWOT Analysis
Table 69. Octapharma Recent Developments
Table 70. Kedrion Corporation Information
Table 71. Kedrion Description and Major Businesses
Table 72. Kedrion Product Features and Attributes
Table 73. Kedrion Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Kedrion Revenue Proportion by Product in 2024
Table 75. Kedrion Revenue Proportion by Application in 2024
Table 76. Kedrion Revenue Proportion by Geographic Area in 2024
Table 77. Kedrion Small Scale Plasma Fractionation SWOT Analysis
Table 78. Kedrion Recent Developments
Table 79. LFB Group Corporation Information
Table 80. LFB Group Description and Major Businesses
Table 81. LFB Group Product Features and Attributes
Table 82. LFB Group Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. LFB Group Recent Developments
Table 84. Biotest Corporation Information
Table 85. Biotest Description and Major Businesses
Table 86. Biotest Product Features and Attributes
Table 87. Biotest Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Biotest Recent Developments
Table 89. BPL Corporation Information
Table 90. BPL Description and Major Businesses
Table 91. BPL Product Features and Attributes
Table 92. BPL Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. BPL Recent Developments
Table 94. RAAS Corporation Information
Table 95. RAAS Description and Major Businesses
Table 96. RAAS Product Features and Attributes
Table 97. RAAS Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. RAAS Recent Developments
Table 99. CBPO Corporation Information
Table 100. CBPO Description and Major Businesses
Table 101. CBPO Product Features and Attributes
Table 102. CBPO Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. CBPO Recent Developments
Table 104. Hualan Bio Corporation Information
Table 105. Hualan Bio Description and Major Businesses
Table 106. Hualan Bio Product Features and Attributes
Table 107. Hualan Bio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Hualan Bio Recent Developments
Table 109. Tiantan Bio Corporation Information
Table 110. Tiantan Bio Description and Major Businesses
Table 111. Tiantan Bio Product Features and Attributes
Table 112. Tiantan Bio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Tiantan Bio Recent Developments
Table 114. Shuanglin Bio Corporation Information
Table 115. Shuanglin Bio Description and Major Businesses
Table 116. Shuanglin Bio Product Features and Attributes
Table 117. Shuanglin Bio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Shuanglin Bio Recent Developments
Table 119. Boya Bio Corporation Information
Table 120. Boya Bio Description and Major Businesses
Table 121. Boya Bio Product Features and Attributes
Table 122. Boya Bio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Boya Bio Recent Developments
Table 124. Yuanda Shuyang Corporation Information
Table 125. Yuanda Shuyang Description and Major Businesses
Table 126. Yuanda Shuyang Product Features and Attributes
Table 127. Yuanda Shuyang Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Yuanda Shuyang Recent Developments
Table 129. Weiguang Bio Corporation Information
Table 130. Weiguang Bio Description and Major Businesses
Table 131. Weiguang Bio Product Features and Attributes
Table 132. Weiguang Bio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. Weiguang Bio Recent Developments
Table 134. Nanyue Bio Corporation Information
Table 135. Nanyue Bio Description and Major Businesses
Table 136. Nanyue Bio Product Features and Attributes
Table 137. Nanyue Bio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. Nanyue Bio Recent Developments
Table 139. KM Biologics Corporation Information
Table 140. KM Biologics Description and Major Businesses
Table 141. KM Biologics Product Features and Attributes
Table 142. KM Biologics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. KM Biologics Recent Developments
Table 144. Raw Materials Key Suppliers
Table 145. Distributors List
Table 146. Market Trends and Market Evolution
Table 147. Market Drivers and Opportunities
Table 148. Market Challenges, Risks, and Restraints
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources


List of Figures
Figure 1. Small Scale Plasma Fractionation Product Picture
Figure 2. Global Small Scale Plasma Fractionation Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Immune Globulin Product Picture
Figure 4. Coagulation Factor Product Picture
Figure 5. Albumin Product Picture
Figure 6. Others Product Picture
Figure 7. Global Small Scale Plasma Fractionation Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Hospital
Figure 9. Retail Pharmacy
Figure 10. Others
Figure 11. Small Scale Plasma Fractionation Report Years Considered
Figure 12. Global Small Scale Plasma Fractionation Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Small Scale Plasma Fractionation Revenue (2020-2031) & (US$ Million)
Figure 14. Global Small Scale Plasma Fractionation Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Small Scale Plasma Fractionation Revenue Market Share by Region (2020-2031)
Figure 16. Global Small Scale Plasma Fractionation Revenue Market Share Ranking (2024)
Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 18. Immune Globulin Revenue Market Share by Player in 2024
Figure 19. Coagulation Factor Revenue Market Share by Player in 2024
Figure 20. Albumin Revenue Market Share by Player in 2024
Figure 21. Others Revenue Market Share by Player in 2024
Figure 22. Global Small Scale Plasma Fractionation Revenue Market Share by Type (2020-2031)
Figure 23. Global Small Scale Plasma Fractionation Revenue Market Share by Application (2020-2031)
Figure 24. North America Small Scale Plasma Fractionation Revenue YoY (2020-2031) & (US$ Million)
Figure 25. North America Top 5 Players Small Scale Plasma Fractionation Revenue (US$ Million) in 2024
Figure 26. North America Small Scale Plasma Fractionation Revenue (US$ Million) by Type (2020 - 2031)
Figure 27. North America Small Scale Plasma Fractionation Revenue (US$ Million) by Application (2020-2031)
Figure 28. US Small Scale Plasma Fractionation Revenue (2020-2031) & (US$ Million)
Figure 29. Canada Small Scale Plasma Fractionation Revenue (2020-2031) & (US$ Million)
Figure 30. Mexico Small Scale Plasma Fractionation Revenue (2020-2031) & (US$ Million)
Figure 31. Europe Small Scale Plasma Fractionation Revenue YoY (2020-2031) & (US$ Million)
Figure 32. Europe Top 5 Players Small Scale Plasma Fractionation Revenue (US$ Million) in 2024
Figure 33. Europe Small Scale Plasma Fractionation Revenue (US$ Million) by Type (2020-2031)
Figure 34. Europe Small Scale Plasma Fractionation Revenue (US$ Million) by Application (2020-2031)
Figure 35. Germany Small Scale Plasma Fractionation Revenue (2020-2031) & (US$ Million)
Figure 36. France Small Scale Plasma Fractionation Revenue (2020-2031) & (US$ Million)
Figure 37. U.K. Small Scale Plasma Fractionation Revenue (2020-2031) & (US$ Million)
Figure 38. Italy Small Scale Plasma Fractionation Revenue (2020-2031) & (US$ Million)
Figure 39. Russia Small Scale Plasma Fractionation Revenue (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Small Scale Plasma Fractionation Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Top 8 Players Small Scale Plasma Fractionation Revenue (US$ Million) in 2024
Figure 42. Asia-Pacific Small Scale Plasma Fractionation Revenue (US$ Million) by Type (2020-2031)
Figure 43. Asia-Pacific Small Scale Plasma Fractionation Revenue (US$ Million) by Application (2020-2031)
Figure 44. Indonesia Small Scale Plasma Fractionation Revenue (2020-2031) & (US$ Million)
Figure 45. Japan Small Scale Plasma Fractionation Revenue (2020-2031) & (US$ Million)
Figure 46. South Korea Small Scale Plasma Fractionation Revenue (2020-2031) & (US$ Million)
Figure 47. Australia Small Scale Plasma Fractionation Revenue (2020-2031) & (US$ Million)
Figure 48. India Small Scale Plasma Fractionation Revenue (2020-2031) & (US$ Million)
Figure 49. Indonesia Small Scale Plasma Fractionation Revenue (2020-2031) & (US$ Million)
Figure 50. Vietnam Small Scale Plasma Fractionation Revenue (2020-2031) & (US$ Million)
Figure 51. Malaysia Small Scale Plasma Fractionation Revenue (2020-2031) & (US$ Million)
Figure 52. Philippines Small Scale Plasma Fractionation Revenue (2020-2031) & (US$ Million)
Figure 53. Singapore Small Scale Plasma Fractionation Revenue (2020-2031) & (US$ Million)
Figure 54. Central and South America Small Scale Plasma Fractionation Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Central and South America Top 5 Players Small Scale Plasma Fractionation Revenue (US$ Million) in 2024
Figure 56. Central and South America Small Scale Plasma Fractionation Revenue (US$ Million) by Type (2020-2031)
Figure 57. Central and South America Small Scale Plasma Fractionation Revenue (US$ Million) by Application (2020-2031)
Figure 58. Brazil Small Scale Plasma Fractionation Revenue (2020-2025) & (US$ Million)
Figure 59. Argentina Small Scale Plasma Fractionation Revenue (2020-2025) & (US$ Million)
Figure 60. Middle East and Africa Small Scale Plasma Fractionation Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Middle East and Africa Top 5 Players Small Scale Plasma Fractionation Revenue (US$ Million) in 2024
Figure 62. South America Small Scale Plasma Fractionation Revenue (US$ Million) by Type (2020-2031)
Figure 63. Middle East and Africa Small Scale Plasma Fractionation Revenue (US$ Million) by Application (2020-2031)
Figure 64. GCC Countries Small Scale Plasma Fractionation Revenue (2020-2025) & (US$ Million)
Figure 65. Israel Small Scale Plasma Fractionation Revenue (2020-2025) & (US$ Million)
Figure 66. Egypt Small Scale Plasma Fractionation Revenue (2020-2025) & (US$ Million)
Figure 67. South Africa Small Scale Plasma Fractionation Revenue (2020-2025) & (US$ Million)
Figure 68. Small Scale Plasma Fractionation Industry Chain Mapping
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies